WebbUnit Purchase Agreement, dated August 13, 2024, by and among Recro Pharma, Inc., IriSys, LLC, the Sellers (as defined therein), and IriSys, Inc. as the Seller’s Representative (incorporated herein by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on August 13, 2024). 23.1* Consent of KPMG LLP. 23.2* Webb13 aug. 2024 · Recro Pharma acquires Irisys on 2024-08-13 for $50000000. Recro Pharma Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the …
Recro Pharma, Inc. acquired IRISYS, LLC from EPS Americas, Corp ...
Webb13 aug. 2024 · With its acquisition of IRISYS, Recro has transformed itself into a full service CDMO with operations on both the East and West Coast of the U.S. capable of offering its now expanded global client base access to services spanning from pre-Investigational New Drug (IND) development to commercial manufacturing and … WebbIrisys is located in San Diego, California, United States. Who invested in Irisys? Irisys is funded by Simon Murdoch. How much funding has Irisys raised to date? Irisys has … block shuffle data pack
Small Business - The Tidewater News The Tidewater News
Webb13 aug. 2024 · Recro Pharma, a U.S. contract development and manufacturing company, has completed the purchase of rival IRISYS. The company bought IRISYS for $50 million in a combination of cash, shares of Recro common stock, and a seller promissory note. Webb17 aug. 2024 · Recro Pharma Inc., a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for … Webb16 aug. 2024 · Irisys has about $23 million on hand thanks to its contracted stockpile and “vetted sales pipeline,” Recro stated. With the offer under its belt and $2.1 million in Irisys earnings on the horizon, Recro states it will prepare an upgrade to its monetary assistance in the 3rd quarter. RELATED: News of Note– Recro and Novartis extend pact free check on credit score